AFHA — American Family Health Association
Molecular Tumor Panels

Tumor Testing

NGS molecular profiling across 14+ cancer-specific panels to guide targeted therapy.

Overview

Tumor Testing provides next-generation sequencing (NGS) molecular profiling across 14+ cancer-specific panels. By matching a tumor's molecular profile to targeted therapies, it helps oncologists optimize treatment for each patient.

What it offers

NGS molecular profiling
14+ cancer-specific panels
Matches drugs to genetic profile
Supports precision oncology decisions

Who it's for

  • Oncologists optimizing therapy
  • Patients with a cancer diagnosis
  • Practices offering precision medicine